{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-386561","form_type":"8-K","ticker":"CADL","cik":"0001841387","company_name":"Candel Therapeutics, Inc.","filed_at":"2026-09-09T20:50:50+00:00","discovered_at":"2026-09-09T20:52:00.295080+00:00","generated_at":"2026-09-09T20:52:06.770138+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Candel Therapeutics files investor presentation; no new material facts disclosed","bullets":["Candel Therapeutics furnished a corporate investor presentation dated September 2026 under Regulation FD.","Visible exhibit content is limited to the cover slide; no financial or clinical data is included in the filing text.","Presentation tagline: 'Tipping the balance in favor of the immune system to fight cancer.'","No earnings, guidance, or pipeline updates are disclosed in this 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-386561","json":"https://secwatch.observer/filing/0001193125-26-386561.json","markdown":"https://secwatch.observer/filing/0001193125-26-386561.md","text":"https://secwatch.observer/filing/0001193125-26-386561.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841387/000119312526386561/0001193125-26-386561-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841387/000119312526386561/d738484d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-09T20:52:06.770138+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}